Barrow Neurological Institute opens major new neuroscience facility
19 avr. 2022 19h36 HE
|
Barrow Neurological Institute at Dignity Health St. Joseph's Hospital and Medical Center
PHOENIX, April 19, 2022 (GLOBE NEWSWIRE) -- Barrow Neurological Institute has officially opened a new neuroscience facility that is expected to serve as a national model for enhancing the patient...
Dr. Volker W. Stieber, MD, Joins Vivacitas' Neuro-Oncology Advisory Board
07 févr. 2022 10h00 HE
|
Vivacitas Oncology Inc
WALNUT CREEK, Calif., Feb. 07, 2022 (GLOBE NEWSWIRE) -- Vivacitas Oncology, Inc., a privately-held biopharmaceutical company focused on tough-to-treat cancers, is proud to present Dr. Volker W....
Vivacitas Oncology Strengthens Its Neuro-Oncology Board With World-Class Advisor Dr. Katherine Peters, MD, PhD, FAAN
31 janv. 2022 09h00 HE
|
Vivacitas Oncology Inc
WALNUT CREEK, Calif., Jan. 31, 2022 (GLOBE NEWSWIRE) -- Vivacitas Oncology, Inc., a privately-held biopharmaceutical company focused on tough-to-treat cancers, continues to grow its Neuro-Oncology...
Vivacitas Oncology Welcomes Dr. Jai Grewal, MD, and Expands Its Neuro-Oncology Advisory Board
03 janv. 2022 09h00 HE
|
Vivacitas Oncology Inc
WALNUT CREEK, Calif., Jan. 03, 2022 (GLOBE NEWSWIRE) -- Vivacitas Oncology, Inc. ("Vivacitas" or the "Company"), a privately held oncology company focused on tough-to-treat cancers, is pleased to...
Vivacitas Oncology Presents Its New Neuro-Oncology Advisor, Dr. Andrew Lassman MD, MS, FAAN
15 déc. 2021 15h00 HE
|
Vivacitas Oncology Inc
WALNUT CREEK, Calif., Dec. 15, 2021 (GLOBE NEWSWIRE) -- Vivacitas Oncology, Inc. ("Vivacitas" or the "Company"), a privately-held oncology company focused on tough-to-treat cancers, is pleased to...
Incysus Therapeutics to Present at the 2019 Society for Neuro-Oncology (SNO) Annual Meeting
21 nov. 2019 07h00 HE
|
Incysus Therapeutics, Inc.
NEW YORK, Nov. 21, 2019 (GLOBE NEWSWIRE) -- Incysus Therapeutics, Inc. (“Incysus”), a biopharmaceutical company focused on delivering an innovative gamma-delta (γδ) T cell immunotherapy for the...
Sarah Durham Named Chair of the National Brain Tumor Society Board of Directors
10 janv. 2019 15h47 HE
|
National Brain Tumor Society
Boston, MA, Jan. 10, 2019 (GLOBE NEWSWIRE) -- National Brain Tumor Society (NBTS), the largest nonprofit dedicated to the brain tumor community in the United States, has announced the appointment of...
Gamma-Delta (γδ) T Cell Therapy Combined With Checkpoint Inhibition Shows Potential Synergies in Vitro for Treatment of Glioblastoma
15 nov. 2018 07h00 HE
|
Incysus Therapeutics, Inc.
Promising data from gamma-delta (γδ) T cell therapy in combination with checkpoint inhibitors to be presented at 2018 Society for Neuro-Oncology annual meeting NEW YORK, Nov. 15, 2018 (GLOBE...
National Brain Tumor Society Supported Work Features in 19 Presentations at 2018 Society for Neuro-Oncology Annual Meeting
13 nov. 2018 16h37 HE
|
National Brain Tumor Society
Boston, MA, Nov. 13, 2018 (GLOBE NEWSWIRE) -- National Brain Tumor Society (NBTS), the largest nonprofit dedicated to the brain tumor community in the United States, today announced that its funded...
National Brain Tumor Society Launches New Brain Tumor-Specific Clinical Trial Finder
22 mars 2017 08h30 HE
|
National Brain Tumor Society
BOSTON, MA--(Marketwired - March 22, 2017) - National Brain Tumor Society (NBTS), the largest nonprofit dedicated to the brain tumor community in the United States, today announced the launch of the...